| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $58.94B | +7.7% |
| Cost of Revenue | $22.32B | +11.6% |
| R&D Expense | $78.0M | -3.7% |
| SG&A Expense | $893.0M | -22.9% |
| Interest Expense | $855.0M | +9.2% |
| Pre-tax Income | $12.66B | -7.4% |
| Income Tax | $4.67B | +5.4% |
| Net Income | $7.99B | -13.6% |
| EPS (Basic) | $6.36 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.50B | +15.9% |
| Short-term Investments | $484.0M | -4.5% |
| Inventory | $1.87B | +3.5% |
| Current Assets | $15.53B | -0.7% |
| Total Assets | $121.94B | -0.7% |
| Current Liabilities | $11.97B | -1.3% |
| Long-term Debt | $22.42B | -3.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $19.80B | -1.6% |
| Investing Cash Flow | -$8.84B | +20.8% |
| Financing Cash Flow | -$10.10B | -14.3% |
| -18.7% |
| EPS (Diluted) | $6.35 | -18.7% |
| Total Liabilities |
| $57.45B |
| -0.9% |
| Stockholders' Equity | $64.49B | -0.5% |